Oorsprong van het eerstegraads netwerk van David Caouette
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
28
| Subsidiary | Pharmaceuticals: Major | 28 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Caouette via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Investor Relations Contact | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Washington Biotechnology & Biomedical Association | Director/Board Member Director/Board Member | ||
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| University of Florida | College/University | Undergraduate Degree Doctorate Degree | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Medical Specialties | Treasurer Chief Tech/Sci/R&D Officer | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| IMMUNOME, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Woolsey Pharmaceuticals, Inc.
 Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| OPY ACQUISITION CORP. I | Financial Conglomerates | Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Booz Allen Hamilton International (U.K.) Ltd.
 Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin | |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| AXCA HEALPAR | Biotechnology | Chairman | |
| Remedii LLC | Corporate Officer/Principal | ||
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member | |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Financial Conglomerates | Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Chairman | |
Diagnostic Hybrids, Inc.
 Diagnostic Hybrids, Inc. Medical SpecialtiesHealth Technology Diagnostic Hybrids, Inc. develops, manufactures and markets cellular and molecular diagnostic kits. Its products include rapid diagnostics, thyroid testing solutions, respiratory family testing, herpes family testing, chlamydia testing, enterovirus testing, cell lines and media and supplements. The company was founded by Wilfred R. Konneker, Joseph Jollick and Thomas E. Wagner in 1983 and is headquartered in Athens, OH. | Medical Specialties | Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Zwitserland | 3 |
| Canada | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 5 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 161 |
| Independent Dir/Board Member | 78 |
| Corporate Officer/Principal | 67 |
| Chairman | 32 |
| Undergraduate Degree | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| Ted Love | 31 |
| David Epstein | 29 |
| Felix Baker | 28 |
| Daniel Welch | 24 |
| John Orwin | 21 |
| David Gryska | 20 |
| Clay Siegall | 18 |
| Nancy Simonian | 16 |
| Marc Lippman | 14 |
| Todd Simpson | 13 |
| Jean Liu | 13 |
| Vaughn Himes | 11 |
| Alpna Seth | 11 |
| Tuomo Tapani Pätsi | 10 |
| Deborah Baron | 9 |
- Beurs
- Insiders
- David Caouette
- Bedrijfsconnecties
